Fiessinger, J. N.; Vayssairat, M.; Juillet, Y.; Janneau, D.; Cormier, J. M.; Housset, E.
October 1980
Angiology;Oct1980, Vol. 31 Issue 10, p715
Academic Journal
Selective intra-arterial urokinase (UK) is effective in treating recent arterial thromboembolism. However, usually only partials lysis is achieved and this treatment seems less effective than intravenous streptokinase. At a dose of 37,500 UCTA/hour it does not produce systemic fibrinolysis. This protocol substantially reduces the risk of systemic bleeding and embolism and extends its applicability to operative patients. The combination of surgery and UK seems particularly promising in patients with atherosclerotic arterial thrombosis.


Related Articles

  • Local Thrombolysis in Arterial Occlusive Disease. Slany, J.; Enzenhofer, V.; Karnik, R. // Angiology;Apr1984, Vol. 35 Issue 4, p231 

    In a series of 38 subjects intra-arterial catheters were used to infuse streptokinase (SK) or urokinase (UK) just proximal to an acute thromboembolic occlusion in 20 limbs or to perfuse SK directly into the obstructing material in 23 extremities with subacute or chronic occlusions by stepwise...

  • Is Impaired Flow-Mediated Dilatation of the Brachial Artery a Cardiovascular Risk Factor? Agewall, S. // Current Vascular Pharmacology;Jun2003, Vol. 1 Issue 2, p107 

    Endothelial dysfunction is thought to be an important factor in the development of atherosclerosis. Over the past decade, a non-invasive technique has evolved to evaluate flow-mediated vasodilation (FMD), an endothelium-dependent function, in the brachial artery. FMD decreases with increasing...

  • Atherosclerosis - New Targets and Therapeutics. Pillarisetti, Sivaram; Alexander, Christopher W.; Saxena, Uday // Current Medicinal Chemistry - Cardiovascular & Hematological Age;Oct2004, Vol. 2 Issue 4, p327 

    Atherosclerosis is well recognized as an inflammatory disease and circulating markers of inflammation such as C-reactive protein and soluble adhesion molecules are strong predictors of atherosclerotic lesion development and future cardiovascular events. Several cells (endothelial, smooth muscle...

  • Peripheral Arterial Occlusive Disease: Magnetic Resonance Imaging and the Role of Aggressive Medical Management. Lumsden, Alan; Rice, Terry; Chen, Changyi; Zhou, Wei; Lin, Peter; Bray, Paul; Morrisett, Joel; Nambi, Vijay; Ballantyne, Christie // World Journal of Surgery;Apr2007, Vol. 31 Issue 4, p695 

    Atherosclerosis accounts for most peripheral arterial occlusive disease (PAD). Although many of the risk factors for atherosclerotic coronary artery disease (CAD) such as hyperlipidemia have been identified as risk factors for peripheral arterial disease, strong evidence is lacking that risk...

  • Obstructive Vascular Disease Treated by Urokinase. Mazel, M. S.; Riera, R. // Vascular Surgery;Mar/Apr1978, Vol. 12 Issue 2, p113 

    Eleven cases of obstructive peripheral vascular disease were treated with urokinase, including seven cases of occlusion of iliofemoral arteries and four cases of occlusion of femoral and popliteal veins. There was one additional case of complete obstruction of carotid arteries. In every case the...

  • Atrial fibrillation and retinal vein or artery occlusion: looking beyond the eye. Plunkett, Oliver; Lip, Peck Lin; Lip, Gregory Y. H. // British Journal of Ophthalmology;Sep2014, Vol. 98 Issue 9, p1141 

    The authors reflects on epidemiological studies examining the associations of incident retinal emboli, retinal vein occlusion (RVO), and retinal artery occlusion (RAO) with cardiovascular and cerebrovascular diseases. They state that RAO's pathogenesis is generally accepted to be directly...

  • Independent Nurse: What The Papers Said.  // GP: General Practitioner;10/21/2005, p210 

    This article reports on the results of the Venous Thromboembolism (VTE) Impact Assessment Group in Europe study, which indicates that around 1 per cent of the European Union population dies as a result of VTE annually. The British Department of Health recognises that 20,000 patients die from the...

  • Antiplatelet Drugs. Offermanns, Stefan // Encyclopedic Reference of Molecular Pharmacology;2004, p106 

    The article presents an encyclopedia entry for the term "antiplatelet drugs," which are platelet inhibitors used to prevent and treat thrombotic processes. It discusses the mechanism of action of antiplatelet therapy for thromboembolic artery occlusions in cardiovascular diseases. It also...

  • Endogenous Postmenopausal Hormones and Carotid Atherosclerosis: A Case-Control Study of the Atherosclerosis Risk in Communities Cohort. Golden, Sherita Hill; Maguire, Ann; Jingzhong Ding; Crouse, J. R.; Cauley, Jane A.; Zacur, Howard; Szklo, Moyses // American Journal of Epidemiology;Mar2002, Vol. 155 Issue 5, p437 

    Studies examining the relation between endogenous postmenopausal hormone levels and cardiovascular disease have yielded conflicting results. After excluding women with a history of hormone replacement therapy (HRT) use, the authors conducted a US case-control study in 1987–1992 comparing...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics